Loading clinical trials...
Loading clinical trials...
The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Palo Alto Veterans Institute for Research
Collaborators
NCT04128189 · Kidney Transplant Recipient Response to Shingrix Vaccine, Kidney Failure, and more
NCT07462741 · Hemodialysis Patient, Diabetes Foot Care
NCT06001827 · Chronic Kidney Diseases, End Stage Renal Disease, and more
NCT06978127 · Chronic Kidney Disease Requiring Hemodialysis
NCT07153939 · Chronic Kidney Disease, Hemodialysis Access, and more
VA Palo Alto Health Care System
Palo Alto, California
Santa Clara Valley Medical Center
San Jose, California
Satellite HealthCare
San Jose, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions